Cancer cells such as chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL) exploit the antiapoptotic effects of Bcl-2 to survive oncogenic stress, though such cells are primed to death2,3. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.